#United States #New York #Fundstrat #ETF #Granny Shots

Fundstrat Capital's February 2026 Rebalance Update for GRNJ ETF

Fundstrat Capital, under the guidance of Chief Investment Officer Thomas "Tom" Lee, has recently completed the quarterly rebalance for its Granny Shots US Small- & Mid-Cap ETF (NYSE: GRNJ). As of February 23, 2026, the ETF boasts over $384 million in assets under management (AUM), marking it as one of the fastest-growing actively managed small- and mid-cap equity ETFs available on the market today.

What is the Granny Shots ETF?

The Fundstrat Granny Shots ETF operates on a proprietary thematic investment framework designed to highlight small- and mid-cap U.S. equities that are expected to thrive amid various macroeconomic conditions, demographic trends, and technology advancements. The overarching goal of this framework is to dynamically adjust holdings in reaction to changing market landscapes.

Key Changes in the February 2026 Rebalance

The latest rebalance reflects a series of strategic shifts informed by Fundstrat's extensive research. This includes incorporating insights derived from macroeconomic perspectives as well as quantitative data. Notably, the recent adjustments included 18 new additions to the portfolio, while 11 stocks were removed. This proactive approach aims to adapt the ETF's positioning for the ongoing and anticipated market conditions in 2026.

Tom Lee remarked, "Our decision to rebalance is a response to evolving market dynamics and prevailing seasonality trends, ensuring that we maintain a portfolio capable of meeting future performance expectations."

Additions to the Portfolio

Newly added securities to the GRNJ ETF include:

• - ARRY (Array Technologies)
• - CARR (Carrier Global)
• - DPZ (Domino's Pizza)
• - UHS (Universal Health Services)
• - HALO (Halozyme Therapeutics)

These companies have been selected based on their alignment with Fundstrat's research themes, showcasing strong potential growth.

Removed Stocks

Conversely, the rebalance also sees the exit of several companies, including:

• - AYI (Acuity Brands)
• - JOBY (Joby Aviation)
• - RBLX (Roblox)

This reflects a calculated decision to remove stocks that may not align with the fund’s updated strategic outlook.

Thematic Research Approach

The investment strategy employed by Fundstrat combines top-down macroeconomic analysis with bottom-up quantitative screening, allowing for a well-rounded selection process. To qualify for the Granny Shots ETF, a security must emerge in at least two of Fundstrat's identified investment themes, ensuring that each inclusion is supported by multiple expected tailwinds.

In this latest rebalance, the seven themes considered include shorter-term factors such as Seasonality and PMI Recovery, as well as long-term drivers like Global Labor Supply and Cybersecurity. This multi-faceted method enhances the potential for achieving consistent growth in the ETF's performance.

What’s Next for Fundstrat Capital?

Since its launch, Grand Shots has garnered considerable attention from investors, leading to its substantial growth in AUM. This latest rebalance not only solidifies GRNJ’s position in the market but also reflects the increasing investor interest in thematic investment strategies.

In addition to the GRNJ ETF, Fundstrat also offers other products in its Granny Shots suite, including large-cap-focused options like the Fundstrat Granny Shots US Large Cap ETF (NYSE: GRNY). This variety caters to diverse investor preferences and risk appetites, further establishing Fundstrat as a pivotal player in the investment landscape.

For further insights into these developments or to view the complete list of recent changes, interested parties can visit grannyshots.com. Furthermore, for weekly updates from Tom Lee, investors are encouraged to sign up for email notifications on their website.

Conclusion

Fundstrat Capital remains dedicated to aligning its investment strategies with market realities and investor needs. The February 2026 rebalance of the Granny Shots US Small- & Mid-Cap ETF exemplifies a commitment to utilizing rigorous research to enhance portfolio performance, positioning it strategically within an evolving financial landscape.